No headlines found.
Amwell to Participate in Upcoming Investor Conference
Globe Newswire (Tue, 24-Feb 5:00 PM ET)
Amwell makes grant to new employee under inducement plan
Globe Newswire (Wed, 18-Feb 4:30 PM ET)
Amwell Announces Results for Fourth Quarter and Full Year 2025
Globe Newswire (Thu, 12-Feb 4:05 PM ET)
Amwell to report fourth quarter and full year 2025 operating results
Globe Newswire (Thu, 5-Feb 4:05 PM ET)
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
American Well Class A trades on the NYSE stock market under the symbol AMWL.
As of April 2, 2026, AMWL stock price climbed to $5.50 with 22,172 million shares trading.
AMWL has a beta of 1.73, meaning it tends to be more sensitive to market movements. AMWL has a correlation of 0.24 to the broad based SPY ETF.
AMWL has a market cap of $86.95 million. This is considered a Micro Cap stock.
Last quarter American Well Class A reported $55 million in Revenue and -$1.52 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.07.
In the last 3 years, AMWL traded as high as $54.70 and as low as $3.71.
The top ETF exchange traded funds that AMWL belongs to (by Net Assets): VTI, VXF, DFAS, PRFZ, AVSC.
AMWL has underperformed the market in the last year with a price return of -23.3% while the SPY ETF gained +18.2%. However, in the short term, AMWL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.0% vs -3.6% return in SPY. But in the last 2 weeks, AMWL shares have been beat by the market, returning -1.6% compared to an SPY return of -0.6%.
AMWL support price is $5.05 and resistance is $5.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMWL shares will trade within this expected range on the day.